Effect of no Drainage Tube on Blood Loss and Recovery After High Tibial Osteotomy
1 other identifier
interventional
80
1 country
1
Brief Summary
The objective of this study was to evaluate the safety and efficacy of topical combined with intravenous tranexamic acid for high tibial osteotomy without placement of a drainage tube The clinical scores of patients and their possible risks were tracked. The investigators hypothesized that a combination of tranexamic acid and no drainage tube could reduce blood loss and facilitate early recovery. The implementation of the study will provide a new perioperative blood loss control program for High Tibial Osteotomy, reduce the cost of hospitalization, promote patients to get out of bed early, reduce the number of days in hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 6, 2019
CompletedFirst Posted
Study publicly available on registry
May 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedFebruary 19, 2020
May 1, 2019
1.1 years
May 6, 2019
February 16, 2020
Conditions
Outcome Measures
Primary Outcomes (15)
Postoperative blood loss
Total blood loss preoperative blood volume =(preoperative hematocrit-postoperative Hematocrit) + transfusion volume.
The third day after operation
Haemoglobin
Reactive blood loss
The third day after operation
Hematocrit
Reactive blood loss
The third day after operation
Hospital for special surgery knee score
HSS is a knee function scoring system with a full score of 100. 0 means the loss of knee function, 100 means the best knee function, and the greater the value, the better knee function.
postoperative 3 month
Visual Analogue Scale Postoperative Day One
Draw a 10 cm horizontal line on the paper. One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain. The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
Postoperative Day One
Visual Analogue Scale Postoperative Day Three
Draw a 10 cm horizontal line on the paper. One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain. The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
Postoperative Day Three
Visual Analogue Scale Postoperative Day Five
Draw a 10 cm horizontal line on the paper. One end of the line is 0, indicating no pain; the other end is 10, indicating severe pain; and the middle part indicates varying degrees of pain. The patient selects a point from the horizontal line and the length from 0 to this point is the Visual Analogue Scale score.
Postoperative Day Five
Circumference of shank Postoperative Day One
indirectly reflects the latent blood loss
Postoperative Day One
Circumference of shank Postoperative Day Three
indirectly reflects the latent blood loss
Postoperative Day Three
Circumference of shank Postoperative Day Five
indirectly reflects the latent blood loss
Postoperative Day Five
Number of blood transfusions
If the hemoglobin was \<80 g/l, allogeneic blood was transfused, and the number of blood transfusions were recorded.0 means no blood transfusion, and the larger the number is, the more blood transfusion.The maximum number does not exceed the total number of patients
Postoperative Day Three
Number of Incision infection
The incision was red, swollen, hot and painful, and the blood routine showed that the leukocyte was increased.
postoperative 3 month
Number of hematoma formation
After operation, the incision is swollen and has wave motion, but it is not hot or painful, and there will be blood outflow during puncture.
postoperative 3 month
Number of delayed healing of the incision.
On the 14th day after operation, the incision did not heal.
On the 14th day after operation
Volume of drainage
Reactive blood loss
Postoperative Day One
Secondary Outcomes (4)
Activated partial thromboplastin time
The third day after operation
Prothrombin time
The third day after operation
Concentration of D-dimer
The third day after operation
Concentration of Fibrinogen
The third day after operation
Study Arms (2)
No Drainage
EXPERIMENTALThe preoperative dose of tranexamic acid was calculated according to 20 mg / kg body weight, 100 ml of tranexamic acid sodium chloride solution was dripped 30 minutes before operation, and 30 ml saline containing 2 g tranexamic acid was applied to the local area before loosening the tourniquet.Postoperative intravenous drip of 100 ML sodium chloride solution containing 20 mg / kg tranexamic acid. No drainage tube was placed after operation.
Drainage
ACTIVE COMPARATORThe preoperative dose of tranexamic acid was calculated according to 20 mg / kg body weight, 100 ml of tranexamic acid sodium chloride solution was dripped 30 minutes before operation, and 30 ml saline containing 2 g tranexamic acid was applied to the local area before loosening the tourniquet.Postoperative intravenous drip of 100 ML sodium chloride solution containing 20 mg / kg tranexamic acid. Drainage tube should be placed after operation.
Interventions
The drainage tube drainage to guide the pus, blood and liquid accumulated between human tissues or in body cavity outside the body of High tibial osteotomy'patients.
Tranexamic acid (TXA) is an anti-fibrinolytic drugcan,which can increase the stability of fibrin clots and achieve hemostasis for High tibial osteotomy'patients.
Sodium Chloride 0.9% is a solution of sodium chloride, which has the same osmotic pressure as animal or human plasma in physiological experiments or clinics, and can be used to dilute Tranexamic Acid .
Eligibility Criteria
You may qualify if:
- Simple knee medial compartment osteoarthritis High tibial osteotomy.
- With varus deformity, medial proximal tibia angle \<85°
- Unilateral High tibial osteotomy
- informed consent: Participants must be able to understand and voluntarily sign a written informed consent and follow the research protocol and interview process
You may not qualify if:
- patients who underwent other knee surgery within 6 months
- Preoperative combined anemia (Hb\<100g/l)
- Patients with severe cardiovascular, hepatic, renal and hematopoietic diseases
- Patient with preoperative coagulation abnormalities 5. Patients with allergies and patients allergic to TXA.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qilu hospital of Shandong University
Jinan, Shandong, 250014, China
Related Publications (9)
Kim KI, Kim HJ, Kim GB, Bae SH. Tranexamic acid is effective for blood management in open-wedge high tibial osteotomy. Orthop Traumatol Surg Res. 2018 Nov;104(7):1003-1007. doi: 10.1016/j.otsr.2018.07.019. Epub 2018 Sep 20.
PMID: 30245067BACKGROUNDPalanisamy JV, Das S, Moon KH, Kim DH, Kim TK. Intravenous Tranexamic Acid Reduces Postoperative Blood Loss After High Tibial Osteotomy. Clin Orthop Relat Res. 2018 Nov;476(11):2148-2154. doi: 10.1097/CORR.0000000000000378.
PMID: 29939895BACKGROUNDSuh DW, Kyung BS, Han SB, Cheong K, Lee WH. Efficacy of Tranexamic Acid for Hemostasis in Patients Undergoing High Tibial Osteotomy. J Knee Surg. 2018 Jan;31(1):50-55. doi: 10.1055/s-0037-1600091. Epub 2017 Mar 29.
PMID: 28355682BACKGROUNDZhang Q, Zhang Q, Guo W, Liu Z, Cheng L, Zhu G. No need for use of drainage after minimally invasive unicompartmental knee arthroplasty: a prospective randomized, controlled trial. Arch Orthop Trauma Surg. 2015 May;135(5):709-13. doi: 10.1007/s00402-015-2192-z. Epub 2015 Mar 8.
PMID: 25750137BACKGROUNDHuang Z, Xie X, Li L, Huang Q, Ma J, Shen B, Kraus VB, Pei F. Intravenous and Topical Tranexamic Acid Alone Are Superior to Tourniquet Use for Primary Total Knee Arthroplasty: A Prospective, Randomized Controlled Trial. J Bone Joint Surg Am. 2017 Dec 20;99(24):2053-2061. doi: 10.2106/JBJS.16.01525.
PMID: 29257010BACKGROUNDChan JJ, Cirino CM, Huang HH, Poeran J, Mazumdar M, Parsons BO, Anthony SG, Galatz LM, Cagle PJ Jr. Drain Use is Associated with Increased Odds of Blood Transfusion in Total Shoulder Arthroplasty: A Population-Based Study. Clin Orthop Relat Res. 2019 Jul;477(7):1700-1711. doi: 10.1097/CORR.0000000000000728.
PMID: 30985612BACKGROUNDLegnani C, Oriani G, Parente F, Ventura A. Reducing transfusion requirements following total knee arthroplasty: effectiveness of a double infusion of tranexamic acid. Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2253-2256. doi: 10.26355/eurrev_201903_17273.
PMID: 30915773BACKGROUNDNishitani K, Kuriyama S, Nakamura S, Ito H, Matsuda S. A Multivariate Analysis on the Effect of No Closed Suction Drain on the Length of Hospital Stay in Total Knee Arthroplasty. Knee Surg Relat Res. 2019 Mar 1;31(1):25-30. doi: 10.5792/ksrr.18.013.
PMID: 30871289BACKGROUNDLi S, Yang J, Watson C, Lu Q, Zhang M, Miao Z, Luo D, Liu P. Drainage relieves pain without increasing post-operative blood loss in high tibial osteotomy: a prospective randomized controlled study. Int Orthop. 2020 Jun;44(6):1037-1043. doi: 10.1007/s00264-020-04530-z. Epub 2020 Mar 14.
PMID: 32172314DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Peilai Liu, Ph.D
Qilu Hospital of Shandong University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2019
First Posted
May 17, 2019
Study Start
August 1, 2018
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
February 19, 2020
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share
The datasets used and/or analysed during the current study are available from the overall study officials on reasonable request.